Cart
sales@molnova.com
BCI-137
CAS No. 112170-24-8
BCI-137 ( BCI 137; BCI137 )
Catalog No. M27752 CAS No. 112170-24-8
BCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | Get Quote |
|
| 10MG | 402 | Get Quote |
|
| 25MG | 664 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | 1242 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBCI-137
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
-
DescriptionBCI-137 is an Argonaute 2 ligand. It acts by targeting the MicroRNA Binding Domain.
-
SynonymsBCI 137; BCI137
-
PathwayOthers
-
TargetOther Targets
-
RecptorLPS-TLR4/MD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112170-24-8
-
Formula Weight313.3
-
Molecular FormulaC11H11N3O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(NS(=O)(=O)c1ccc2[nH]c(=O)c(=O)[nH]c2c1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yi Wang, et al. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2. J Pharmacol Exp Ther. 2015 Jun;353(3):539-50
molnova catalog
related products
-
SUN 11602
SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.
-
INT
INT is used in various dehydrogenase colorimetric analysis of the electron acceptor.
-
Pseudoprotodioscin
1. Pseudoprotodioscin has moderate cytotoxicity.
